Quantification of counterparty risks and regulatory timeline
In 2017, as in previous years, important regulatory deadlines are set. Numerous amendments in particular to the clearing obligation, the bilateral collateralisation and the trade reporting of OTC derivatives, as well as the transparency of securities financing transactions will enter into force. These requirements concern all financial counterparties and partly also non-financial counterparties. To prepare for 2017 deadlines, we have attached an overview of already known EMIR and SFTR dates.